Bank of America Corporation 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 7:34 pm Sale | 2023-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BANK OF AMERICA CORP BAC | 442,590 4.400% | -116,600 (-20.85%) | Filing |
| 2023-02-14 07:55 am Purchase | 2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | BANK OF AMERICA CORP BAC | 559,190 5.600% | 559,190 (New Position) | Filing |